Business that Never Ends
0
+
Medical Platform in different specialties
0
+
Users
0
+
Impressions
Our Focus
Our teams, equipped with our range of specialised services, provide accurate and relevant information that will help you make smarter decisions, faster and more consistently across markets
Our Products
We develop innovative, patented, and exclusive digital platforms in the form of mobile applications and websites with a focus on the healthcare industry
latest News
18 April 2024
Directly from the USA: AI Tools Help Predict Complications Following Lower-Extremity Fracture
Directly from the USA: AI Tools Help Predict Complications Following Lower-Extremity Fracture Use of...
18 April 2024
From the USA: Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant
From the USA: Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant Bilateral Wilms...
17 April 2024
ACC 2024: Short Sleep Duration Linked to Risk of Developing Hypertension
ACC 2024: Short Sleep Duration Linked to Risk of Developing Hypertension Short sleep duration is associated...
17 April 2024
From ACC 2024: Small but Significant Risk for Cardiomyopathy Seen With ADHD Meds
From ACC 2024: Small but Significant Risk for Cardiomyopathy Seen With ADHD Meds Young adults prescribed...
17 April 2024
Broadcasted from ACC 2024: Coronary Artery Calcium Progression May Accelerate After Menopause
Broadcasted from ACC 2024: Coronary Artery Calcium Progression May Accelerate After Menopause Postmenopausal...
17 April 2024
Reported from ACC 2024: Binge Drinking Further Increases CVD Risk With High Alcohol Consumption
Reported from ACC 2024: Binge Drinking Further Increases CVD Risk With High Alcohol Consumption High...
17 April 2024
News Coverage from ACC 2024: AI-Based Video Biomarker Detects Aortic Stenosis Progression
News Coverage from ACC 2024: AI-Based Video Biomarker Detects Aortic Stenosis Progression A video-based...
17 April 2024
ACC 2024: Empagliflozin Cuts Heart Failure Hospitalization Risk After AMI
ACC 2024: Empagliflozin Cuts Heart Failure Hospitalization Risk After AMI For patients with acute myocardial...
17 April 2024
From ACC 2024: Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
From ACC 2024: Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome Treatment with ticagrelor...
17 April 2024
Directly from ACC 2024: Ventura Shunt Does Not Improve Primary End Point in Heart Failure
Directly from ACC 2024: Ventura Shunt Does Not Improve Primary End Point in Heart Failure For patients...